摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,5,7-trimethyl-pyrazolo[1,5-a]pyrimidine | 61552-54-3

中文名称
——
中文别名
——
英文名称
3,5,7-trimethyl-pyrazolo[1,5-a]pyrimidine
英文别名
3,5,7-Trimethylpyrazolo[1,5-a]pyrimidine
3,5,7-trimethyl-pyrazolo[1,5-<i>a</i>]pyrimidine化学式
CAS
61552-54-3
化学式
C9H11N3
mdl
——
分子量
161.206
InChiKey
SBRLSFLXAOFBDJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    12
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    30.2
  • 氢给体数:
    0
  • 氢受体数:
    2

文献信息

  • PYRROLOPYRAZINE-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS
    申请人:Hadida Ruah Sara Sabina
    公开号:US20120196869A1
    公开(公告)日:2012-08-02
    The invention relates to pyrrolopyrazine-spirocyclic piperidine amide compounds useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.
    这项发明涉及对离子通道具有抑制作用的吡咯嘧啶-螺环哌啶酰胺化合物。该发明还提供了包括该发明化合物的药学上可接受的组合物,以及使用这些组合物治疗各种疾病的方法。
  • AROMATIC COMPOUND
    申请人:Mitsubishi Tanabe Pharma Corporation
    公开号:EP1956009A1
    公开(公告)日:2008-08-13
    An aromatic compound represented by the following formula or a pharmaceutically acceptable salt thereof: , wherein ring A is a heterocyclic ring, ring B is a carbocyclic ring, a heterocyclic ring etc., G1, G2, G3, G4 and G5 are CH or N, X is -NH-, -O-, -CH2-, etc., Y is - CH2-,-CO-,-SO2- etc., Z is a single bond, -CO-, -SO2-, -NH-, -O-, -S-, -CONH-,-SO2NH-, etc., R2 is hydrogen, alkyl, alkoxy, halogen, etc., and R3 is carbocyclic group, heterocyclic group, alkyl, etc., is useful as a controlling agent of the function of CCR4 useful for the treatment or therapy for bronchial asthma, atopic dermatitis, etc.
    以下公式表示的芳香族化合物或其药用可接受盐: 其中,环A是杂环,环B是碳环、杂环等,G1、G2、G3、G4和G5是CH或N,X是-NH-、-O-、-CH2-等,Y是- -、-CO-、-SO2-等,Z是单键、-CO-、-SO2-、-NH-、-O-、-S-、-CONH-、-SO2NH-等,R2是氢、烷基、烷氧基、卤素等,R3是碳环组、杂环组、烷基等, 作为控制CCR4功能的调节剂,对治疗或治疗支气管哮喘、特应性皮炎等疾病很有用。
  • [EN] SUBSTITUTED 4-METHYL-PYRROLO[1.2-A]PYRIMIDINE-8-CARBOXAMIDE COMPOUNDS AND USES THEREOF FOR MODULATING GLUCOCEREBROSIDASE ACTIVITY<br/>[FR] COMPOSÉS DE 4-MÉTHYL-PYRROLO[1,2-A]PYRIMIDINE-8-CARBOXAMIDE SUBSTITUÉ ET LEURS UTILISATIONS POUR MODULER L'ACTIVITÉ DE LA GLUCOCÉRÉBROSIDASE
    申请人:UNIV NORTHWESTERN
    公开号:WO2017004408A1
    公开(公告)日:2017-01-05
    Disclosed are new small molecules having a 4-methylpyrrrolo[l,2-a]pyrimidine- 8-carboxamide core structure and the uses thereof for modulating glucocerebrosidase activity. Also disclosed are pharmaceutical compositions comprising the small molecules which may be administered in methods of treating diseases or disorders associated with glucocerebrosidase activity, including neurological diseases and disorders such as Gaucher's disease and Parkinson's disease. The small molecules may contain a fluorophore or may be conjugated to a fluorophore in order to prepare a fluorescent probe for use in high throughput screening methods to identify new modulators of glucocerebrosidase activity via fluorescence polarization.
    揭示了具有4-甲基吡咯并[1,2-a]嘧啶-8-羧酰胺核结构的新型小分子及其用途,用于调节葡萄糖乙酰脂酶活性。还揭示了包含这些小分子的药物组合物,可用于治疗与葡萄糖乙酰脂酶活性相关的疾病或疾病,包括神经系统疾病和障碍,如高雪氏病和帕森病。这些小分子可能含有荧光团或与荧光团结合,以制备用于高通量筛选方法中的荧光探针,以通过荧光极化识别葡萄糖乙酰脂酶活性的新调节剂。
  • Diamine Derivative, Process of Preparation Thereof, and Fungicide Comprising Diamine Derivative as an Active Ingredient
    申请人:Kakimoto Takeshi
    公开号:US20070244153A1
    公开(公告)日:2007-10-18
    It is an object of the invention to provide a novel fungicide which exhibits a wide controlling spectrum against pathogens of various crops, and solves the toleration problem. The diamine derivative represented by the formula (1) and a process for preparation of the same, fungicides comprising the same as an active ingredient are disclosed: [wherein R1 is substituents such as an alkyl group having 1 to 6 carbon atoms and the like, R2 and R5 are each independently substituents such as hydrogen atom, an alkyl group having 1 to 6 carbon atoms and the like, R3 and R4 are each independently substituents such as hydrogen atom, an alkyl group having 1 to 6 carbon atoms and the like, or R3 and R4 may be bonded to each other to form a hydrocarbon ring having 3 to 6 carbon atoms, R6, R7, R8 and R9 are each independently substituents such as hydrogen atom, an alkyl group having 1 to 6 carbon atoms and the like, R10 is a substituent such as hydrogen atom, an alkyl group having 1 to 6 carbon atoms and the like, A is an oxygen atom or a sulfur atom, and Q is an aryl group or a heterocycle].
    本发明的目的是提供一种新型杀菌剂,该杀菌剂对各种作物的病原体具有广泛的控制谱,并解决了容忍问题。本发明公开了由式(1)表示的二胺衍生物及其制备方法,以及包含其作为活性成分的杀菌剂:[其中,R1是取代基,例如具有1到6个碳原子的烷基等,R2和R5各自独立地是氢原子、具有1到6个碳原子的烷基等取代基,R3和R4各自独立地是氢原子、具有1到6个碳原子的烷基等取代基,或者R3和R4可以结合在一起形成具有3到6个碳原子的碳氢环,R6、R7、R8和R9各自独立地是氢原子、具有1到6个碳原子的烷基等取代基,R10是氢原子、具有1到6个碳原子的烷基等取代基,A是氧原子或原子,Q是芳基或杂环]。
  • Imidazo&lsqb;1,2-A&rsqb; Pyridine Anxiolytics
    申请人:Fang Q. Kevin
    公开号:US20080096867A1
    公开(公告)日:2008-04-24
    Imidazo[1,2-a]pyridines of the formulae I and II: are disclosed. The compounds are useful to treat anxiety and insomnia. Pharmaceutical compositions and methods are also disclosed. A representative compound of the invention is:
    公开了式I和式II的咪唑[1,2-a]吡啶化合物。这些化合物可用于治疗焦虑和失眠。还公开了制药组合物和方法。该发明的代表性化合物为:
查看更多

同类化合物

阿拉格列汀 间型霉素环-3',5'-单磷酸酯 西地那非杂质 西地那非-嘧啶酮杂质 苯甲腈,4-(5-甲基-1,3-噁噻戊环-2-基)-(9CI) 苯,[(1-甲基环戊基)硫代]- 苄基-(6-氯-1-甲基-1H-吡唑并[3,4-d]嘧啶-4-基)-胺 羟基氯地那非 磷酸二氢2-甲氧基-5-[(Z)-2-(3,4,5-三甲氧苯基)乙烯基]苯酯 盐(1:?)1,3,5-萘三磺酸,7-[2-[4-[[5-氯-6-甲基-2-(甲磺酰)-4-嘧啶基]氨基]苯基]二氮烯基]-,钠 甲基-(6-甲基磺酰基-1(2)H-吡唑并[3,4-d]嘧啶-4-基)-胺 甲基(1R,2S,4S)-2,5,7-三羟基-6,11-二羰基-2-(2-羰基丙基)-4-{[2,3,6-三脱氧-4-O-(2,6-二脱氧-α-L-来苏-六吡喃糖基)-3-(二甲氨基)-α-L-来苏-六吡喃糖基]氧代}-1,2,3,4,6,11-六氢四省-1-羧酸酯 环己基-(1-甲基-1H-吡唑并[3,4-d]嘧啶-4-基)-胺 氯化[4-[(4-氯苯基)氰基甲基]-5-氯-m-苯甲基]铵 氮杂环庚-1-基-[7-氯-4-噻吩-2-基-2-(三氟甲基)-1,5,9-三氮杂双环[4.3.0]壬-2,4,6,8-四烯-8-基]甲酮 昔多芬杂质 异丙基 4-(1-甲基-7-氧代-3-丙基-6,7-二氢-1H-吡唑并[4,3-d]嘧啶-5-基)噻吩-2-基磺酰基氨基甲酸酯 噁庚并[3,4-c]吡啶-3,9-二酮,5-乙基-1,4,5,8-四氢-5-羟基-,(5R)- 吡啶-2-基-[7-吡啶-4-基-吡唑[1,5-a]嘧啶-3-基]甲酮 吡唑并[2,3-a]嘧啶 吡唑并[1,5-a]嘧啶-7-胺 吡唑并[1,5-a]嘧啶-7(1h)-酮 吡唑并[1,5-a]嘧啶-6-醇 吡唑并[1,5-a]嘧啶-6-羧酸乙酯 吡唑并[1,5-a]嘧啶-6-羧酸 吡唑并[1,5-a]嘧啶-5-羧酸,3-氰基-4,7-二氢-7-羰基-,甲基酯 吡唑并[1,5-a]嘧啶-5-羧酸 吡唑并[1,5-a]嘧啶-3-胺盐酸盐(1:1) 吡唑并[1,5-a]嘧啶-3-胺;三氟乙酸 吡唑并[1,5-a]嘧啶-3-羰酰氯 吡唑并[1,5-a]嘧啶-3-羧酸乙酯 吡唑并[1,5-a]嘧啶-3-羧酸 吡唑并[1,5-a]嘧啶-3-磺酰胺 吡唑并[1,5-a]嘧啶-3-甲酰胺 吡唑并[1,5-a]嘧啶-3-甲腈 吡唑并[1,5-a]嘧啶-2-羧酸乙酯 吡唑并[1,5-a]嘧啶-2-羧酸 吡唑并[1,5-a]嘧啶,2-甲基-6-(1-甲基乙基)- 吡唑并[1,5-a]嘧啶,2-溴-5,7-二甲基- 吡唑并[1,5-A]嘧啶-7-羧酸 吡唑并[1,5-A]嘧啶-5-胺 吡唑并[1,5-A]嘧啶-5(4H)-酮 吡唑并[1,5-A]嘧啶-3-甲醛 吡唑[1,5-A]嘧啶-5-羧酸甲酯 吡唑[1,5-A]嘧啶-5,7(4H,6H)-二酮 双氯地那非 卡巴地那非 别嘌醇 别嘌呤醇D2 依鲁替尼杂质37